An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Treatment Gaining Traction Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to message these accounts privately for source information, while also receiving discount codes.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.
Some professionals said the demand for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or prison.
Service Response and Material Elimination
Based on the social media company, the platform has taken down violative content and prohibited associated keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Digital Marketplace Operations
Research also discovered groups with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
After moments of joining one community, a vendor shared WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, health issues or previous experience.
Product Information and Pricing
Inside these groups, posts show dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Actions
A representative for Telegram stated it regularly moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject users to possibly significant medical dangers”.
